Movement Alert｜Illumina Intraday Rise 5.01%, RBC Raises Target to $310 on Clinical Sequencing Outlook

Market Focus

Oct 06

On October 6, Illumina rose 5.01% in regular trading, trading at $305.46/share, with Turnover of $70.87 million. The move came after RBC Capital Markets raised its price target on the stock to $310 from $230, keeping an outperform rating.

RBC cited durable mid-teens growth in clinical sequencing revenue, driven by oncology volume growth and easing pricing headwinds. The firm also expects BioInsight and the Billion Cell Atlas to add 1 to 2 percentage points to growth in fiscal 2027, while academic research demand may bottom out that year. Recent target increases from Guggenheim, Leerink Partners, and Piper Sandler have further reinforced the bullish view.

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It serves genomic research centers, academic institutions, government laboratories, hospitals, and biotechnology and pharmaceutical companies worldwide.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/news/1153827716"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153827716\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153827716?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-06 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153827716","market":"us","top_or_hot":-1,"title":"Movement Alert｜Illumina Intraday Rise 5.01%, RBC Raises Target to $310 on Clinical Sequencing Outlook","media":"Market Focus","content":"<p><p>On October 6, Illumina rose 5.01% in regular trading, trading at $305.46/share, with Turnover of $70.87 million. The move came after RBC Capital Markets raised its price target on the stock to $310 from $230, keeping an outperform rating.</p><p>RBC cited durable mid-teens growth in clinical sequencing revenue, driven by oncology volume growth and easing pricing headwinds. The firm also expects BioInsight and the Billion Cell Atlas to add 1 to 2 percentage points to growth in fiscal 2027, while academic research demand may bottom out that year. Recent target increases from Guggenheim, Leerink Partners, and Piper Sandler have further reinforced the bullish view.</p><p>Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It serves genomic research centers, academic institutions, government laboratories, hospitals, and biotechnology and pharmaceutical companies worldwide.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Illumina Intraday Rise 5.01%, RBC Raises Target to $310 on Clinical Sequencing Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Illumina Intraday Rise 5.01%, RBC Raises Target to $310 on Clinical Sequencing Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-06 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 6, Illumina rose 5.01% in regular trading, trading at $305.46/share, with Turnover of $70.87 million. The move came after RBC Capital Markets raised its price target on the stock to $310 from $230, keeping an outperform rating.</p><p>RBC cited durable mid-teens growth in clinical sequencing revenue, driven by oncology volume growth and easing pricing headwinds. The firm also expects BioInsight and the Billion Cell Atlas to add 1 to 2 percentage points to growth in fiscal 2027, while academic research demand may bottom out that year. Recent target increases from Guggenheim, Leerink Partners, and Piper Sandler have further reinforced the bullish view.</p><p>Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It serves genomic research centers, academic institutions, government laboratories, hospitals, and biotechnology and pharmaceutical companies worldwide.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ILMN","symbol_name":"Illumina","start_time":0,"source_url":"","article_id":"1153827716","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153827716","pubTimestamp":1791293742,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 6, Illumina rose 5.01% in regular trading, trading at $305.46/share, with Turnover of $70.87 million. The move came after RBC Capital Markets raised its price target on the stock to $310...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ILMN":"Illumina"},"translate_title":"走势警报|Illumina 盘中上涨 5.01%，加拿大皇家银行根据临床测序前景将目标上调至 310 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ILMN":1},"content_text":"On October 6, Illumina rose 5.01% in regular trading, trading at $305.46/share, with Turnover of $70.87 million. The move came after RBC Capital Markets raised its price target on the stock to $310 from $230, keeping an outperform rating.RBC cited durable mid-teens growth in clinical sequencing revenue, driven by oncology volume growth and easing pricing headwinds. The firm also expects BioInsight and the Billion Cell Atlas to add 1 to 2 percentage points to growth in fiscal 2027, while academic research demand may bottom out that year. Recent target increases from Guggenheim, Leerink Partners, and Piper Sandler have further reinforced the bullish view.Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It serves genomic research centers, academic institutions, government laboratories, hospitals, and biotechnology and pharmaceutical companies worldwide.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}